X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-01 | AKRO | Young Jonathan | COO | S - Sale | $24.38 | -5,000 | 587,012 | -1% | -$121,913 | ||||||
2024-03-13 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $28.33 | -723 | 77,692 | -1% | -$20,483 | ||||||
2024-03-13 | AKRO | White William Richard | CFO | S - Sale | $28.33 | -724 | 49,630 | -1% | -$20,511 | ||||||
2024-03-13 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $28.33 | -1,969 | 589,447 | 0% | -$55,782 | ||||||
2024-03-13 | AKRO | Young Jonathan | COO | S - Sale | $28.33 | -651 | 328,306 | 0% | -$18,443 | ||||||
2024-03-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $28.33 | -619 | 182,558 | 0% | -$17,536 | ||||||
| D | 2024-03-04 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $32.87 | -75,000 | 591,416 | -11% | -$2,465,063 | |||||
| D | 2024-03-04 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $35.49 | -20,646 | 78,415 | -21% | -$732,727 | |||||
| D | 2023-12-27 | AKRO | Young Jonathan | COO | S - Sale+OE | $24.00 | -5,414 | 245,131 | -2% | -$129,936 | |||||
2023-12-14 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $20.76 | -597 | 77,910 | -1% | -$12,394 | ||||||
2023-12-14 | AKRO | White William Richard | CFO | S - Sale | $20.76 | -611 | 50,354 | -1% | -$12,684 | ||||||
2023-12-14 | AKRO | Young Jonathan | COO | S - Sale | $20.76 | -543 | 245,131 | 0% | -$11,273 | ||||||
2023-12-14 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $20.76 | -1,628 | 550,911 | 0% | -$33,797 | ||||||
2023-12-14 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $20.76 | -514 | 182,672 | 0% | -$10,671 | ||||||
2023-12-08 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $19.83 | +100,000 | 802,168 | +14% | +$1,982,940 | ||||||
| DM | 2023-12-07 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $20.02 | -26,978 | 552,539 | -5% | -$539,969 | |||||
| M | 2023-11-30 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $16.95 | +100,000 | 702,168 | +17% | +$1,694,565 | |||||
2023-11-17 | AKRO | Young Jonathan | COO | S - Sale | $14.68 | -30,000 | 213,177 | -12% | -$440,259 | ||||||
| D | 2023-10-02 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $47.91 | -25,000 | 460,998 | -5% | -$1,197,827 | |||||
| D | 2023-10-02 | AKRO | Young Jonathan | COO | S - Sale+OE | $51.10 | -490 | 243,177 | 0% | -$25,039 | |||||
2023-09-13 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $50.34 | -1,682 | 460,998 | 0% | -$84,672 | ||||||
2023-09-13 | AKRO | White William Richard | CFO | S - Sale | $50.34 | -632 | 18,468 | -3% | -$31,815 | ||||||
| DM | 2023-09-13 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $48.32 | -5,617 | 46,010 | -11% | -$271,416 | |||||
2023-09-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $50.34 | -531 | 150,689 | 0% | -$26,731 | ||||||
2023-09-13 | AKRO | Young Jonathan | COO | S - Sale | $50.34 | -562 | 243,177 | 0% | -$28,291 | ||||||
| D | 2023-09-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $49.77 | -25,000 | 462,680 | -5% | -$1,244,248 | |||||
| D | 2023-08-28 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $49.99 | -5,745 | 46,627 | -11% | -$287,191 | |||||
2023-08-08 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $42.06 | +25,000 | 602,168 | +4% | +$1,051,475 | ||||||
| D | 2023-08-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $43.15 | -25,000 | 447,680 | -5% | -$1,078,867 | |||||
| M | 2023-07-28 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $42.95 | +55,000 | 577,168 | +11% | +$2,362,234 | |||||
| D | 2023-07-03 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $44.88 | -25,000 | 447,680 | -5% | -$1,122,041 | |||||
| M | 2023-06-21 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $51.74 | -33,349 | 46,627 | -42% | -$1,725,390 | |||||
| D | 2023-06-20 | AKRO | White William Richard | CFO | S - Sale+OE | $55.00 | -20,777 | 19,100 | -52% | -$1,142,735 | |||||
| D | 2023-06-16 | AKRO | Heyman Tomas J. | Dir | S - Sale+OE | $54.67 | -26,000 | 0 | -100% | -$1,421,529 | |||||
| D | 2023-06-16 | AKRO | Henderson Jane | Dir | S - Sale+OE | $54.17 | -40,000 | 0 | -100% | -$2,166,685 | |||||
| D | 2023-06-16 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $54.78 | -78,200 | 151,220 | -34% | -$4,284,066 | |||||
2023-06-13 | AKRO | White William Richard | CFO | S - Sale | $55.16 | -606 | 22,377 | -3% | -$33,427 | ||||||
2023-06-13 | AKRO | Cheng Andrew | Pres, CEO | S - Sale | $55.16 | -1,613 | 407,680 | 0% | -$88,973 | ||||||
2023-06-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $55.16 | -509 | 189,420 | 0% | -$28,076 | ||||||
2023-06-13 | AKRO | Young Jonathan | COO | S - Sale | $55.16 | -538 | 243,739 | 0% | -$29,676 | ||||||
2023-06-13 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $55.16 | -591 | 79,976 | -1% | -$32,600 | ||||||
| AM | 2022-09-19 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $29.69 | +520,000 | 522,168 | >999% | +$15,440,000 | |||||
| D | 2023-06-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $45.10 | -25,000 | 409,293 | -6% | -$1,127,430 | |||||
| M | 2023-09-19 | AKRO | Graham G. Walmsley | Dir | P - Purchase | $29.69 | +520,000 | 522,168 | >999% | +$15,440,000 | |||||
| D | 2023-05-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $45.07 | -25,000 | 409,293 | -6% | -$1,126,860 | |||||
| D | 2023-04-03 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $37.94 | -25,000 | 369,293 | -6% | -$948,576 | |||||
| D | 2023-03-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $46.65 | -25,000 | 370,999 | -6% | -$1,166,338 | |||||
| D | 2023-02-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $49.06 | -25,000 | 370,999 | -6% | -$1,226,395 | |||||
2023-01-13 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $50.53 | -5,000 | 81,268 | -6% | -$252,651 | ||||||
| D | 2023-01-03 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $51.27 | -25,000 | 370,999 | -6% | -$1,281,751 | |||||
| D | 2023-01-03 | AKRO | Young Jonathan | COO | S - Sale+OE | $54.64 | -8,777 | 244,911 | -3% | -$479,560 | |||||
| DM | 2022-12-28 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $50.97 | -22,016 | 190,532 | -10% | -$1,122,125 | |||||
| DM | 2022-12-27 | AKRO | White William Richard | CFO | S - Sale+OE | $49.77 | -20,000 | 23,624 | -46% | -$995,323 | |||||
| D | 2022-12-27 | AKRO | Young Jonathan | COO | S - Sale+OE | $49.57 | -12,500 | 242,449 | -5% | -$619,609 | |||||
| D | 2022-12-12 | AKRO | Yale Catriona | Chief Development Officer | S - Sale+OE | $43.23 | -5,000 | 86,268 | -5% | -$216,137 | |||||
2022-12-01 | AKRO | Skorpios Trust | Former 10% owner | S - Sale | $43.50 | -1,636,000 | 3,271,829 | -33% | -$71,166,000 | ||||||
| D | 2022-12-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $46.07 | -10,000 | 310,148 | -3% | -$460,700 | |||||
2022-11-30 | AKRO | Harrison Seth Loring | Dir | S - Sale | $46.94 | -23,131 | 284,364 | -8% | -$1,085,739 | ||||||
| M | 2022-11-15 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $45.28 | -7,085 | 183,837 | -4% | -$320,806 | |||||
2022-11-10 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $39.42 | -5,000 | 72,073 | -6% | -$197,105 | ||||||
| D | 2022-11-01 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $43.42 | -10,000 | 310,148 | -3% | -$434,183 | |||||
2022-10-28 | AKRO | Harrison Seth Loring | Dir | S - Sale | $40.31 | -44,103 | 307,495 | -13% | -$1,777,829 | ||||||
| M | 2022-10-25 | AKRO | Harrison Seth Loring | Dir | S - Sale | $42.71 | -285,487 | 351,598 | -45% | -$12,193,196 | |||||
| DM | 2022-10-25 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $45.07 | -15,415 | 190,922 | -7% | -$694,782 | |||||
| D | 2022-10-25 | AKRO | Young Jonathan | COO | S - Sale+OE | $44.72 | -12,500 | 223,254 | -5% | -$558,944 | |||||
| AD | 2022-09-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $29.18 | -22,500 | 233,837 | -9% | -$656,550 | |||||
| D | 2022-10-13 | AKRO | White William Richard | CFO | S - Sale+OE | $39.82 | -20,000 | 4,429 | -82% | -$796,400 | |||||
2022-10-10 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $37.99 | -5,000 | 77,073 | -6% | -$189,950 | ||||||
| D | 2022-10-06 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $39.29 | -22,500 | 186,337 | -11% | -$884,025 | |||||
| D | 2022-10-03 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $33.23 | -10,000 | 310,148 | -3% | -$332,279 | |||||
| D | 2022-09-30 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale+OE | $32.72 | -45,000 | 198,837 | -18% | -$1,472,400 | |||||
| D | 2022-09-13 | AKRO | Cheng Andrew | Pres, CEO | S - Sale+OE | $27.42 | -60,000 | 310,148 | -16% | -$1,645,444 | |||||
2022-09-13 | AKRO | Yale Catriona | Chief Development Officer | S - Sale | $27.48 | -40,000 | 82,073 | -33% | -$1,099,228 | ||||||
| D | 2022-09-13 | AKRO | White William Richard | CFO | S - Sale+OE | $27.03 | -32,500 | 4,429 | -88% | -$878,341 | |||||
2022-09-13 | AKRO | Rolph Timothy | Chief Scientific Officer | S - Sale | $29.18 | -22,500 | 223,837 | -9% | -$656,550 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |